Harold H. Shlevin - Net Worth and Insider Trading

Harold H. Shlevin Net Worth

The estimated net worth of Harold H. Shlevin is at least $17,639 dollars as of 2025-01-04. Harold H. Shlevin is the Director of Galectin Therapeutics Inc and owns about 15,206 shares of Galectin Therapeutics Inc (GALT) stock worth over $17,639. Details can be seen in Harold H. Shlevin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Harold H. Shlevin has not made any transactions after 2024-12-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Harold H. Shlevin

To

Harold H. Shlevin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Harold H. Shlevin owns 1 companies in total, including Galectin Therapeutics Inc (GALT) .

Click here to see the complete history of Harold H. Shlevin’s form 4 insider trades.

Insider Ownership Summary of Harold H. Shlevin

Ticker Comapny Transaction Date Type of Owner
GALT Galectin Therapeutics Inc 2024-12-30 director & Chief Executive Officer

Harold H. Shlevin Latest Holdings Summary

Harold H. Shlevin currently owns a total of 1 stock. Harold H. Shlevin owns 15,206 shares of Galectin Therapeutics Inc (GALT) as of December 30, 2024, with a value of $17,639.

Latest Holdings of Harold H. Shlevin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GALT Galectin Therapeutics Inc 2024-12-30 15,206 1.16 17,639

Holding Weightings of Harold H. Shlevin


Harold H. Shlevin Form 4 Trading Tracker

According to the SEC Form 4 filings, Harold H. Shlevin has made a total of 1 transactions in Galectin Therapeutics Inc (GALT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Galectin Therapeutics Inc is the acquisition of 6,500 shares on December 30, 2024, which cost Harold H. Shlevin around $7,540.

Insider Trading History of Harold H. Shlevin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Harold H. Shlevin Trading Performance

GuruFocus tracks the stock performance after each of Harold H. Shlevin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Harold H. Shlevin is 162.03%. GuruFocus also compares Harold H. Shlevin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Harold H. Shlevin within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Harold H. Shlevin's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Harold H. Shlevin

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 31.19 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 30.12 LIMIT LIMIT LIMIT LIMIT LIMIT

Harold H. Shlevin Ownership Network

Ownership Network List of Harold H. Shlevin

No Data

Ownership Network Relation of Harold H. Shlevin

Insider Network Chart

Harold H. Shlevin Owned Company Details

What does Galectin Therapeutics Inc do?

Who are the key executives at Galectin Therapeutics Inc?

Harold H. Shlevin is the director & Chief Executive Officer of Galectin Therapeutics Inc. Other key executives at Galectin Therapeutics Inc include Chief Financial Officer Jack W Callicutt , 10 percent owner 10x Fund, L.p. , and director & 10 percent owner Richard E Uihlein .

Galectin Therapeutics Inc (GALT) Insider Trades Summary

Over the past 18 months, Harold H. Shlevin made 1 insider transaction in Galectin Therapeutics Inc (GALT) with a net purchase of 6,500. Other recent insider transactions involving Galectin Therapeutics Inc (GALT) include a net purchase of 16,867 shares made by Kary Eldred , a net purchase of 26,300 shares made by Kevin D Freeman , and a net purchase of 14,500 shares made by Zordani Richard A. Jr. .

In summary, during the past 3 months, insiders sold 109,654 shares of Galectin Therapeutics Inc (GALT) in total and bought 51,769 shares, with a net sale of 57,885 shares. During the past 18 months, 134,654 shares of Galectin Therapeutics Inc (GALT) were sold and 65,167 shares were bought by its insiders, resulting in a net sale of 69,487 shares.

Galectin Therapeutics Inc (GALT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Galectin Therapeutics Inc Insider Transactions

No Available Data

Harold H. Shlevin Mailing Address

Above is the net worth, insider trading, and ownership report for Harold H. Shlevin. You might contact Harold H. Shlevin via mailing address: C/o Galectin Therapeutics, Inc., 4690 Peachtree Industrial Blvd, Ste. 240, Norcross Ga 30071.

Discussions on Harold H. Shlevin

No discussions yet.